One or Two Doses?

Angie Szumlinski Health, Studies

Arguments have been made that because COVID-19 is such a serious disease that is rapidly spreading throughout the world and because vaccines can be made and delivered at a relatively slow rate, a first dose should be given and the second dose delayed until a large amount of the population receives the first dose. To be clear, it is known …

The Debate – One or Two Doses

Angie Szumlinski Health, Studies

Health experts have conditionally backed the U.K.’s decision to delay administering a second dose of the coronavirus vaccine developed by Pfizer and BioNTech, warning that the need to suppress the new coronavirus strain “cannot be overstated.”  On December 30, 2020, following MHRA approval of the Oxford AstraZeneca vaccine, the four UK Chief Medical Officers, based on a recommendation by the …

Israel Sees 60% Drop in Hospitalizations

Angie Szumlinski News, Studies

The full effects of Pfizer’s vaccine are only slated to kick in around a month after the first shot, but data from Israel, home to the world’s fastest vaccination drive, has already shown that there is a stark drop in infections even before this point. Drawing widespread, international interest by sharing early data, Maccabi Healthcare Services reported earlier this month …

Pfizer First Dose – Allergic Reactions

Angie Szumlinski Studies

On December 11, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine, administered as two doses separated by 21 days. Notifications and reports of suspected severe allergic reactions and anaphylaxis following vaccination were captured in the Vaccine Adverse Event Reporting System (VAERS), the national passive surveillance (spontaneous …

NSAIDs or Acetaminophen

Angie Szumlinski Health, Studies

More people with fever and body aches are turning to non-steroidal anti-inflammatory drugs (NSAIDs) to ease symptoms, but the drugs have come under new scrutiny as investigators work to determine whether they are a safe way to relieve the pain of COVID-19 vaccination or symptoms of the disease. One theory is that NSAIDs alter susceptibility to infection by modifying angiotensin-converting …

Hats off to Vaccine Manufacturers

Angie Szumlinski News

Moderna Inc. (Nasdaq: MRNA) announced results from in vitro neutralization studies of sera from individuals vaccinated with the Moderna COVID-19 vaccine showing activity against emerging strains of SARS-CoV-2. Vaccination with the Moderna COVID-19 vaccine produced neutralizing titers against all key emerging variants tested, including B.1.1.7 and B.1.351, first identified in the U.K. and Republic of South Africa. The two-dose regimen …

Risk Assessment and Testing Considerations – Congregate Care Facilities

Angie Szumlinski Announcements, Health

Over a million Americans reside in Congregate Care Facilities (CCFs), which provide housing and some services for individuals who do not need skilled nursing care. CCFs include assisted living facilities, independent living facilities, and memory care units. While healthier than nursing home residents, CCF residents face substantial risk of excess death and morbidity from COVID-19. Many residents and staff in …

New President – New Plan

Angie Szumlinski Announcements, News

President Joseph R. Biden has unveiled a plan to jump-start the nation’s faltering COVID-19 vaccine effort that will include establishing mass vaccination sites and mobile vaccine clinics around the nation. The plan calls for a $20 billion investment in a national vaccination program. According to the CDC, 31 million COVID-19 doses have been distributed and 12.2 million have been administered …

Vaccines – The Continuing Saga!

Angie Szumlinski Health, News

Federal health officials in recent days have urged broadening vaccine eligibility to tens of millions of Americans to speed the national inoculation program rollout. Meanwhile, seniors at some long-term care facilities, who account for about 1% of the U.S. population but 40% of COVID-19 deaths and were supposed to be at the front of the line, continue to wait. State …

Anaphylaxis is Real!

Angie Szumlinski Health, News

Anaphylaxis is a severe, life-threatening allergic reaction that occurs rarely after vaccination. Early safety monitoring of the Pfizer-BioNTech COVID-19 vaccine has detected 21 cases of anaphylaxis after reported administration of 1,893,360 first doses of Pfizer-BioNTech COVID-19 vaccine. Most anaphylaxis cases had symptom onset within 30 minutes of vaccination and most persons with anaphylaxis had a history of allergies or allergic …